Invention Grant
- Patent Title: Pharmaceutical compound for treating colorectal cancer
-
Application No.: US16529366Application Date: 2019-08-01
-
Publication No.: US10849861B2Publication Date: 2020-12-01
- Inventor: Se-Chun Liao , Su-Fen Chen
- Applicant: Everest Pharm. Industrial Co., LTD. , Se-Chun Liao
- Applicant Address: TW Chiayi County TW Chiayi
- Assignee: EVEREST PHARM. INDUSTRIAL CO., LTD.,Se-Chun Liao
- Current Assignee: EVEREST PHARM. INDUSTRIAL CO., LTD.,Se-Chun Liao
- Current Assignee Address: TW Chiayi County TW Chiayi
- Agency: Muncy, Geissler, Olds & Lowe, P.C.
- Priority: TW107127143A 20180803
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61P35/00
Abstract:
A pharmaceutical compound TG1 (2, 3, 5, 4′-tetrahydroxy-trans-stilbene) and a new use for treating colorectal cancer thereof are provided. The pharmaceutical composition of the present invention has the structure of formula shown as below. Each variable in formula I and treating method are detailed in the specification.
Public/Granted literature
- US20200038340A1 PHARMACEUTICAL COMPOUND FOR TREATING COLORECTAL CANCER Public/Granted day:2020-02-06
Information query
